Atea Pharmaceuticals, Inc. (AVIR)
4.115
-0.20
(-4.52%)
USD |
NASDAQ |
Oct 30, 16:00
4.115
0.00 (0.00%)
After-Hours: 20:00
Atea Pharmaceuticals Market Cap : 330.04M for Oct. 30, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 29, 2026 | 345.68M |
| October 28, 2026 | 342.47M |
| October 27, 2026 | 334.45M |
| October 26, 2026 | 333.65M |
| October 23, 2026 | 324.03M |
| October 22, 2026 | 324.83M |
| October 21, 2026 | 327.24M |
| October 20, 2026 | 358.11M |
| October 19, 2026 | 352.10M |
| October 16, 2026 | 346.48M |
| October 15, 2026 | 363.33M |
| October 14, 2026 | 371.35M |
| October 13, 2026 | 399.42M |
| October 12, 2026 | 403.43M |
| October 09, 2026 | 413.05M |
| October 08, 2026 | 413.46M |
| October 07, 2026 | 401.83M |
| October 06, 2026 | 406.64M |
| October 05, 2026 | 411.45M |
| October 02, 2026 | 411.45M |
| October 01, 2026 | 409.04M |
| September 30, 2026 | 417.87M |
| September 29, 2026 | 415.46M |
| September 28, 2026 | 417.06M |
| September 25, 2026 | 414.66M |
| Date | Value |
|---|---|
| September 24, 2026 | 414.66M |
| September 23, 2026 | 423.48M |
| September 22, 2026 | 452.35M |
| September 21, 2026 | 435.51M |
| September 18, 2026 | 427.49M |
| September 17, 2026 | 421.88M |
| September 16, 2026 | 413.05M |
| September 15, 2026 | 419.47M |
| September 14, 2026 | 426.69M |
| September 11, 2026 | 425.89M |
| September 10, 2026 | 415.46M |
| September 09, 2026 | 422.68M |
| September 08, 2026 | 455.56M |
| September 04, 2026 | 467.59M |
| September 03, 2026 | 466.79M |
| September 02, 2026 | 457.17M |
| September 01, 2026 | 440.32M |
| August 31, 2026 | 429.10M |
| August 28, 2026 | 429.90M |
| August 27, 2026 | 437.12M |
| August 26, 2026 | 441.93M |
| August 25, 2026 | 435.51M |
| August 24, 2026 | 441.93M |
| August 21, 2026 | 435.51M |
| August 20, 2026 | 429.90M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Filana Therapeutics, Inc. | 30.10M |
| CorMedix, Inc. | 442.31M |
| Eloxx Pharmaceuticals, Inc. | 53.60M |
| Breakthrough Chemistry, Inc. | 0.8562M |
| BioStem Technologies, Inc. | 19.96M |
Market Cap Related Metrics
| PEG Ratio | -0.0662 |
| Price to Book Value | 1.617 |
| Price | 4.115 |
| Earnings Yield | -50.82% |
| PEGY Ratio | -0.0662 |